It also boosts fat metabolism and energy (ATP) production, essential for cell health and reducing harmful reactive oxygen species (ROS)

Extra caution is advised in people with: A history of pancreatitis Severe acidity or gastroparesis (very slow stomach emptying) Known gallstones or gallbladder disease Advanced kidney disease Significant diabetic eye disease (retinopathy) A very low BMI or a history of eating disorders Pregnancy, plans to become pregnant, or breastfeeding, since some GLP-1 medicines stay in the body for several weeks after stopping Significant depression, who should be monitored carefully Upcoming surgery, endoscopy, or a procedure needing anaesthesia or sedation, since delayed stomach emptying can raise aspiration risk and temporary stopping may be advised How GLP-1 side effects usually progress: a typical timeline Every person is different, but clinical practice and studies suggest a rough pattern [6]: First 2 to 6 weeks: nausea, early fullness, and constipation are most common
Genet Mol Res 15 (2016)
Growth factors are neuroprotective in Alzheimers disease and Parkinsons disease The growth factor signaling mechanism is reduced in the brains of AD and PD, and growth factors have neuroprotective effects (Nagahara et al., 2009
The cutting-edge RNAseq approach of this study also provided an exciting opportunity for investigating the integrated cross-kingdom interactions of multibiome such as viruses (other than SARS-CoV-2) and archaea which contributed about 20.0% of the total microbial sequence reads